Relation of insulin treatment for type 2 diabetes to the risk of major adverse cardiovascular events after acute coronary syndrome: an analysis of the BETonMACE randomized clinical trial

Schwartz, G. G., Nicholls, S. J., Toth, P. P., Sweeney, M., Halliday, C., Johansson, J. O., Wong, N. C. W., Kulikowski, E., Kalantar-Zadeh, K., Ginsberg, H. N., & Ray, K. K. (2021). Relation of insulin treatment for type 2 diabetes to the risk of major adverse cardiovascular events after acute coronary syndrome: an analysis of the BETonMACE randomized clinical trial. Cardiovascular Diabetology, 20(1). https://doi.org/10.1186/s12933-021-01311-9
Authors:
Gregory G. Schwartz
Stephen J. Nicholls
Peter P. Toth
Michael Sweeney
Christopher Halliday
Jan O. Johansson
Norman C. W. Wong
Ewelina Kulikowski
Kamyar Kalantar-Zadeh
Henry N. Ginsberg
Kausik K. Ray
Affiliated Authors:
Henry N. Ginsberg
Author Keywords:
acute coronary syndrome
bet proteins
diabetes
epigenetics
Publication Type:
Article
Unique ID:
10.1186/s12933-021-01311-9
PMID:
Publication Date:
Data Source:
Scopus

Record Created: